Simrat Randhawa MD, MBA in

Simrat Randhawa MD, MBA

Login to view DISC.
Head of Research And Development at Dianthus Therapeutics, Inc.
📍 Seattle, Washington, United States

Dr. Simrat Randhawa serves as the Chief Medical Officer at Dianthus Therapeutics, where he leads clinical development, medical affairs, and regulatory strategy for autoimmune and rare disease treatments. He holds an MD from Drexel University and an MBA from Columbia Business School, with previous leadership roles at Aurinia Pharmaceuticals and Novartis.

He has a unique background that blends over 20 years of clinical practice and pharmaceutical industry experience with strategic business planning, having held roles within a US CEOs office at Novartis.

Read the full overview →
Current Role
Head of Research And Development
Location
Seattle, Washington, United States
Personality Overview

How Simrat shows up

Communication Style
Decision Approach
Work Preference

Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.

Login to view personality overview.
Priorities

Topics Simrat cares about

Clinical Trials
He recently expressed pride and gratitude for his team's successful data readout in a first-in-patient trial, showing his direct involvement in clinical development milestones.
Autoimmune Diseases
His career is focused on autoimmune conditions, having led medical affairs for the Multiple Sclerosis franchise at Novartis and serving as CMO for Dianthus's complement therapeutics.
+5 more topics Login to view topics
Career

Work history

10-2025
Head of Research And Development
Dianthus Therapeutics, Inc.
4-2022 - 10-2025
Chief Medical Officer
Dianthus Therapeutics, Inc.
2-2019 - 4-2022
SVP Medical and Clinical Affairs
Aurinia Pharmaceuticals Inc.
2-2017 - 2-2019
Head Medical Affairs
Aurinia Pharmaceuticals Inc.
3-2012 - 4-2022
Lead Medical Director Multiple Sclerosis
Novartis
In the press

Media appearances

Dianthus Therapeutics, Inc. (DNTH) Phase 2 MaGic Data Investor Webcast Transcript. Featured in Seeking Alpha
See now
Education
2003 - 2005
MBA
Columbia Business School
1991 - 1995
md
Drexel University College of Medicine
Social presence
in
Behavioral profile

DISC profile (public)

DISC behavioral profile

Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.

Login to view DISC.

Other Dianthus Therapeutics, Inc. Employees

Explore more public profiles from related professionals.

Ryan Savitz
Ryan Savitz
Chief Financial Officer & Chief Business Officer
Dianthus Therapeutics, Inc.
 Tom Chen
Tom Chen
Senior Director, Head of Drug Substance and MSAT
Dianthus Therapeutics, Inc.

More profiles

Discover additional public profiles from our index.

Nicholas Schellinger
Nicholas Schellinger
Director of Business Development, Indianapolis
Garmong Construction
 David Sedlock
David Sedlock
Chief Data Officer - Data, AI and Analytics
Zayo Group
 Marcel Teunissen
Marcel Teunissen
President
Parkland Corporation
 Christopher Augustin
Christopher Augustin
SVP, Chief Information Officer, Global Business Solutions
Fiserv
Unlock the full playbookSee exactly how to sell to Simrat. Free, 10 seconds.